Public Health Initiatives FDA Public Health Government Oversight Pharmaceutical Oversight Public Safety Healthcare Oversight Healthcare Ethics FDA Oversight Cannabis Legislation Affordable Medications Pharmacy Oversight Lachgas Government Action Federal Drug Commissioner Public Health Law Pharmaceutical Accountability Government Agencies FDA Actions Federal Agencies Substance Control Pharmaceutical Companies Law Enforcement NHS Guidelines Pharmaceutical Benefits Advisory Committee Transparency in Pricing Marijuana Rescheduling Addiction Treatment Policy State Actions Legislative Reform FDA Leadership Anti-Counterfeiting Measures Pricing Policies Safety Standards Pharmaceutical Pricing Healthcare Fraud Weight Loss Drugs Lifestyle Choices Obesity Management Performance-Enhancing Drugs
New disclosures show continued lobbying on pricing, Medicare coverage, and access despite public deals with the Trump administration.
